[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 26 of about 26
1. Sameshima S, Tomozawa S, Koketsu S, Okada T, Miyato H, Iijima M, Kojima M, Kaji T: Intramucosal adenocarcinoma of the ileum originated 40 years after ileosigmoidostomy. World J Surg Oncol; 2009;7:41
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intramucosal adenocarcinoma of the ileum originated 40 years after ileosigmoidostomy.
  • A mucosal biopsy specimen showed adenocarcinoma histopathologically.
  • Histological examination revealed a well differentiated intramucosal adenocarcinoma (adenocarcinoma in situ).
  • Immunohistological staining demonstrated the overexpression of p53 protein in the adenocarcinoma.
  • CONCLUSION: Adenocarcinoma of the ileum at such an early stage is a very rare event.
  • [MeSH-major] Adenocarcinoma / etiology. Appendicitis / surgery. Colon, Sigmoid / surgery. Ileal Neoplasms / etiology. Ileostomy / adverse effects. Postoperative Complications / etiology

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Appendicitis.
  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Colorectal Dis. 2003 May;18(3):276-8 [12785331.001]
  • [Cites] Dis Colon Rectum. 2002 Nov;45(11):1496-502 [12432298.001]
  • [Cites] Cancer. 2004 Aug 1;101(3):518-26 [15274064.001]
  • [Cites] Arch Pathol Lab Med. 1982 Jun;106(6):308-9 [6896439.001]
  • [Cites] Hum Pathol. 1983 Nov;14(11):931-68 [6629368.001]
  • [Cites] Dis Colon Rectum. 1985 Jun;28(6):383-8 [4006632.001]
  • [Cites] Ann Surg. 1989 Jun;209(6):764-73 [2543338.001]
  • [Cites] CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30 [15661684.001]
  • [Cites] Int J Clin Pract Suppl. 2005 Apr;(147):106-8 [15875642.001]
  • [Cites] Endoscopy. 2005 Aug;37(8):755-9 [16032496.001]
  • [Cites] Cancer Causes Control. 2005 Sep;16(7):781-7 [16132788.001]
  • [Cites] Int J Colorectal Dis. 2006 Jul;21(5):478-82 [16365680.001]
  • [Cites] Am J Gastroenterol. 2006 Jul;101(7):1647-54 [16863573.001]
  • [Cites] Dig Dis Sci. 2008 Feb;53(2):474-80 [17676397.001]
  • [Cites] Dis Colon Rectum. 2009 Mar;52(3):538-41 [19333060.001]
  • [Cites] Dis Colon Rectum. 2000 Jan;43(1):101-4 [10813131.001]
  • [Cites] Int J Colorectal Dis. 2001 Apr;16(2):126-30 [11355319.001]
  • [Cites] World J Surg. 2002 Mar;26(3):390-6 [11865380.001]
  • [Cites] Am J Gastroenterol. 2003 Jun;98(6):1423-7 [12818291.001]
  • (PMID = 19379525.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2676285
  •  go-up   go-down


2. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA; 2008 Jan 30;299(4):425-36
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
  • DESIGN, SETTING, AND PATIENTS: MicroRNA microarray expression profiling of tumors and paired nontumorous tissues was performed on a US test cohort of 84 patients with incident colon adenocarcinoma, recruited between 1993 and 2002.
  • In situ hybridization demonstrated miR-21 to be expressed at high levels in colonic carcinoma cells.

  • COS Scholar Universe. author profiles.
  • SciCrunch. ArrayExpress: Data: Microarray .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9 [12434020.001]
  • [Cites] Pharmacogenomics J. 2007 Oct;7(5):297-304 [17189960.001]
  • [Cites] Cell. 2003 Apr 4;113(1):25-36 [12679032.001]
  • [Cites] Curr Biol. 2003 Apr 29;13(9):790-5 [12725740.001]
  • [Cites] Mol Cancer Res. 2003 Oct;1(12):882-91 [14573789.001]
  • [Cites] Science. 2004 Jan 2;303(5654):83-6 [14657504.001]
  • [Cites] Cell. 2004 Jan 23;116(2):281-97 [14744438.001]
  • [Cites] J Mol Biol. 2004 May 28;339(2):327-35 [15136036.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9740-4 [15210942.001]
  • [Cites] Stat Med. 1985 Jan-Mar;4(1):87-90 [3992076.001]
  • [Cites] Cell. 1990 Jun 1;61(5):759-67 [2188735.001]
  • [Cites] Cell. 1993 Dec 3;75(5):843-54 [8252621.001]
  • [Cites] Cell. 1993 Dec 3;75(5):855-62 [8252622.001]
  • [Cites] Nature. 2005 Jun 9;435(7043):828-33 [15944707.001]
  • [Cites] Nature. 2005 Jun 9;435(7043):834-8 [15944708.001]
  • [Cites] Dis Colon Rectum. 2005 Jun;48(6):1161-8 [15868237.001]
  • [Cites] Cancer Res. 2005 Jul 15;65(14):6029-33 [16024602.001]
  • [Cites] Cancer Res. 2005 Aug 15;65(16):7065-70 [16103053.001]
  • [Cites] N Engl J Med. 2005 Oct 27;353(17):1793-801 [16251535.001]
  • [Cites] Cancer Res. 2005 Nov 1;65(21):9628-32 [16266980.001]
  • [Cites] Nature. 2005 Dec 1;438(7068):685-9 [16258535.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 [16461460.001]
  • [Cites] Cancer Cell. 2006 Mar;9(3):189-98 [16530703.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3687-92 [16505370.001]
  • [Cites] Nat Rev Cancer. 2006 Apr;6(4):259-69 [16557279.001]
  • [Cites] Arch Med Res. 2006 May;37(4):548-51 [16624657.001]
  • [Cites] Gastroenterology. 2006 Jun;130(7):2113-29 [16762633.001]
  • [Cites] Mol Cancer. 2006;5:29 [16854228.001]
  • [Cites] Nat Genet. 2006 Sep;38(9):1060-5 [16878133.001]
  • [Cites] Nat Rev Cancer. 2006 Nov;6(11):857-66 [17060945.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18680-4 [17121985.001]
  • [Cites] Am J Respir Cell Mol Biol. 2007 Jan;36(1):8-12 [16917074.001]
  • [Cites] CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66 [17237035.001]
  • [Cites] Cancer Res. 2007 Feb 1;67(3):976-83 [17283129.001]
  • [Cites] Curr Mol Med. 2007 Feb;7(1):29-46 [17311531.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2750-5 [17293455.001]
  • [Cites] Oncogene. 2007 Apr 26;26(19):2799-803 [17072344.001]
  • [Cites] JAMA. 2007 May 2;297(17):1901-8 [17473300.001]
  • [Cites] JAMA. 2007 May 2;297(17):1923-5 [17473304.001]
  • [Cites] J Biol Chem. 2007 May 11;282(19):14328-36 [17363372.001]
  • [CommentIn] JAMA. 2008 Jun 11;299(22):2628; author reply 2628-9 [18544721.001]
  • (PMID = 18230780.001).
  • [ISSN] 1538-3598
  • [Journal-full-title] JAMA
  • [ISO-abbreviation] JAMA
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / / Z01 BC005480-22
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / MIRN21 microRNA, human; 0 / MicroRNAs; 0 / RNA, Neoplasm
  • [Other-IDs] NLM/ NIHMS82855; NLM/ PMC2614237
  •  go-up   go-down


3. Wang LB, Zheng S, Zhang SZ, Peng JP, Ye F, Fang SC, Wu JM: Expression of ST13 in colorectal cancer and adjacent normal tissues. World J Gastroenterol; 2005 Jan 21;11(3):336-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIM: To investigate the in situ expression of suppression of tumorigenecity 13 (ST13) mRNA in both colorectal cancer and adjacent normal tissues.
  • METHODS: Colorectal cancer cell lines SW1116, SW620 and CoLo205 were enrolled to confirm the feasibility of the in situ hybridization procedure.
  • Seven colorectal cancer and adjacent normal tissues were included for RNA-RNA in situ hybridization.
  • Only three of the seven colorectal cancer tissues had positive hybridization signals that appeared in adenocarcinoma cells.
  • ST13 is mostly expressed in colorectal epithelia and adenocarcinoma cells.
  • [MeSH-major] Adenocarcinoma / metabolism. Carrier Proteins / metabolism. Colon / metabolism. Colorectal Neoplasms / metabolism. Intestinal Mucosa / metabolism. Rectum / metabolism. Tumor Suppressor Proteins / metabolism
  • [MeSH-minor] Adult. Aged. Cell Line, Tumor. Feasibility Studies. Humans. In Situ Hybridization. Middle Aged

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15637739.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Carrier Proteins; 0 / ST13 protein, human; 0 / Tumor Suppressor Proteins
  • [Other-IDs] NLM/ PMC4205332
  •  go-up   go-down


Advertisement
4. Coffey JC, Wang JH, Bouchier-Hayes D, Cotter TG, Redmond HP: The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy. Ann Surg; 2006 Feb;243(2):250-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Balb/c mice underwent a tail vein injection of 1x10 metastatic murine mammary adenocarcinoma 4T1 cells.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / pathology. Adenocarcinoma / surgery. Chromones / pharmacology. Enzyme Inhibitors / pharmacology. Lung Neoplasms / drug therapy. Lung Neoplasms / pathology. Lung Neoplasms / surgery. Morpholines / pharmacology. Neoplasm Recurrence, Local / prevention & control. Neoplasms, Experimental / drug therapy. Neoplasms, Experimental / pathology. Neoplasms, Experimental / surgery. Phosphatidylinositol 3-Kinases / antagonists & inhibitors
  • [MeSH-minor] Animals. Apoptosis. Blotting, Western. Cell Division. In Situ Nick-End Labeling. Laparotomy. Mice. Mice, Inbred BALB C. Neoplasm Metastasis. Tumor Cells, Cultured

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 1999 Dec;81(8):1311-7 [10604727.001]
  • [Cites] J Natl Cancer Inst. 2000 Feb 16;92(4):347-8 [10675389.001]
  • [Cites] Clin Cancer Res. 2000 Mar;6(3):880-6 [10741711.001]
  • [Cites] Surg Endosc. 2000 May;14(5):490-4 [10858479.001]
  • [Cites] Br J Surg. 2001 Mar;88(3):371-5 [11260101.001]
  • [Cites] J Surg Res. 2001 Jun 1;98(1):27-32 [11368534.001]
  • [Cites] Br J Cancer. 2001 Jul 20;85(2):273-8 [11461089.001]
  • [Cites] Br J Cancer. 2001 Aug 17;85(4):490-2 [11506484.001]
  • [Cites] Oncogene. 2001 Sep 13;20(41):5799-809 [11593385.001]
  • [Cites] Trends Mol Med. 2001 Oct;7(10):455-62 [11597520.001]
  • [Cites] J Surg Res. 2001 Dec;101(2):111-9 [11735264.001]
  • [Cites] J Clin Invest. 2002 Jan;109(1):141-9 [11781359.001]
  • [Cites] Mol Cell Biol. 2002 Feb;22(3):965-77 [11784871.001]
  • [Cites] Oncogene. 2002 Jan 10;21(2):319-27 [11803475.001]
  • [Cites] Cancer Res. 2002 Feb 15;62(4):1087-92 [11861387.001]
  • [Cites] Science. 2002 May 31;296(5573):1655-7 [12040186.001]
  • [Cites] Nat Rev Cancer. 2002 Jul;2(7):489-501 [12094235.001]
  • [Cites] Lancet. 2002 Jun 29;359(9325):2224-9 [12103285.001]
  • [Cites] Cancer Res. 2002 Sep 1;62(17):4929-37 [12208743.001]
  • [Cites] Nature. 2002 Dec 19-26;420(6917):860-7 [12490959.001]
  • [Cites] Oncogene. 2003 Jun 26;22(26):4092-101 [12821943.001]
  • [Cites] Lancet. 2003 Aug 16;362(9383):502-3 [12932377.001]
  • [Cites] Lancet. 2003 Aug 16;362(9383):527-33 [12932384.001]
  • [Cites] Cancer Sci. 2003 Dec;94(12):1066-73 [14662022.001]
  • [Cites] Lancet Oncol. 2003 Dec;4(12):760-8 [14662433.001]
  • [Cites] Cancer. 1980 Mar 15;45(6):1498-506 [6153570.001]
  • [Cites] N Engl J Med. 1986 Dec 25;315(26):1650-9 [3537791.001]
  • [Cites] J Surg Oncol. 1994 Jul;56(3):178-84 [8028350.001]
  • [Cites] Cell. 1994 Oct 21;79(2):315-28 [7525077.001]
  • [Cites] Science. 1995 Apr 7;268(5207):100-2 [7701328.001]
  • [Cites] Nat Med. 1995 Feb;1(2):149-53 [7585012.001]
  • [Cites] Lancet. 1995 Dec 9;346(8989):1506-7 [7491042.001]
  • [Cites] Cell. 1997 Jan 24;88(2):277-85 [9008168.001]
  • [Cites] Br J Surg. 1997 Mar;84(3):358-61 [9117307.001]
  • [Cites] Cell. 1997 Oct 17;91(2):231-41 [9346240.001]
  • [Cites] J Clin Invest. 1998 Mar 1;101(5):1055-63 [9486976.001]
  • [Cites] Arch Surg. 1998 Apr;133(4):383-9 [9565118.001]
  • [Cites] Dis Colon Rectum. 1998 May;41(5):564-9 [9593237.001]
  • [Cites] Surgery. 1998 Sep;124(3):516-25 [9736904.001]
  • [Cites] Br J Surg. 1998 Oct;85(10):1439-42 [9782033.001]
  • [Cites] Nat Genet. 1999 Jan;21(1):99-102 [9916799.001]
  • [Cites] Br J Cancer. 1999 Mar;79(9-10):1392-8 [10188881.001]
  • [Cites] Br J Surg. 1999 Sep;86(9):1180-4 [10504374.001]
  • [Cites] Ann Thorac Surg. 2005 Mar;79(3):990-5; discussion 990-5 [15734421.001]
  • [Cites] J Biol Chem. 2005 Jun 3;280(22):20968-77 [15741161.001]
  • (PMID = 16432359.001).
  • [ISSN] 0003-4932
  • [Journal-full-title] Annals of surgery
  • [ISO-abbreviation] Ann. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chromones; 0 / Enzyme Inhibitors; 0 / Morpholines; 154447-36-6 / 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; EC 2.7.1.- / Phosphatidylinositol 3-Kinases
  • [Other-IDs] NLM/ PMC1448916
  •  go-up   go-down


5. Semino-Mora C, Liu H, McAvoy T, Nieroda C, Studeman K, Sardi A, Dubois A: Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Ann Surg Oncol; 2008 May;15(5):1414-23
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND AND AIMS: Pseudomyxoma peritonei (PMP) is characterized by peritoneal tumors arising from a perforated appendiceal adenoma or adenocarcinoma, but associated entry of enteric bacteria in the peritoneum has not been considered as a cofactor.
  • METHODS: In situ hybridization was performed on resection specimens from five control subjects with noninflamed, nonperforated, non-neoplastic appendix and 16 patients with PMP [six with disseminated peritoneal adenomucinosis (DPAM) and 10 with peritoneal mucinous carcinomatosis (PMCA)].

  • Genetic Alliance. consumer health - Pseudomyxoma peritonei.
  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Infect Immun. 1993 May;61(5):1799-809 [8478069.001]
  • [Cites] Lancet. 1992 Nov 14;340(8829):1194-5 [1359263.001]
  • [Cites] J Histochem Cytochem. 1995 Feb;43(2):115-23 [7529784.001]
  • [Cites] Am J Surg Pathol. 1995 Dec;19(12):1390-408 [7503361.001]
  • [Cites] Clin Infect Dis. 1996 Jul;23(1):101-6 [8816137.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):967-72 [9023366.001]
  • [Cites] Mutat Res. 1997 Jun 13;391(1-2):79-86 [9219551.001]
  • [Cites] Hum Pathol. 1998 Oct;29(10):1128-33 [9781653.001]
  • [Cites] Toxicon. 1999 May;37(5):815-23 [10219991.001]
  • [Cites] J Immunol. 1999 May 15;162(10):6233-7 [10229869.001]
  • [Cites] Ann Chir. 2005 Feb;130(2):63-9 [15737316.001]
  • [Cites] Lab Invest. 2005 May;85(5):702-15 [15765119.001]
  • [Cites] Dis Colon Rectum. 2005 Jul;48(7):1372-9 [15909071.001]
  • [Cites] Helicobacter. 2006 Feb;11(1):2-9 [16423084.001]
  • [Cites] Am J Surg Pathol. 2006 May;30(5):551-9 [16699309.001]
  • [Cites] Cancer Lett. 2006 Nov 28;244(1):86-90 [16427185.001]
  • [Cites] Inflamm Bowel Dis. 2006 Nov;12(11):1068-83 [17075348.001]
  • [Cites] PLoS Pathog. 2006 Oct;2(10):e110 [17121461.001]
  • [Cites] Gastroenterology. 2007 Feb;132(2):551-61 [17258726.001]
  • [Cites] Gastroenterology. 2007 Mar;132(3):1009-23 [17383424.001]
  • [Cites] J Am Coll Surg. 2007 May;204(5):943-53; discussion 953-5 [17481516.001]
  • [Cites] Biochim Biophys Acta. 1998 Apr 28;1406(3):251-9 [9630659.001]
  • [Cites] Br J Surg. 2001 Mar;88(3):458-63 [11260116.001]
  • [Cites] Mod Pathol. 2001 Mar;14(3):164-71 [11266521.001]
  • [Cites] J Radiol. 2001 Apr;82(4):463-8 [11353901.001]
  • [Cites] Surg Today. 2001;31(7):646-50 [11495161.001]
  • [Cites] Am J Pathol. 2002 Jun;160(6):2253-7 [12057927.001]
  • [Cites] Am J Pathol. 2002 Aug;161(2):551-64 [12163380.001]
  • [Cites] Mod Pathol. 2002 Sep;15(9):958-72 [12218214.001]
  • [Cites] Mol Pharmacol. 2002 Nov;62(5):1112-8 [12391274.001]
  • [Cites] J Obstet Gynaecol. 2002 Mar;22(2):223 [12521714.001]
  • [Cites] J Infect Dis. 2003 Apr 15;187(8):1165-77 [12695995.001]
  • [Cites] Int J Gynecol Cancer. 2003 Jul-Aug;13(4):413-8 [12911716.001]
  • [Cites] Ann Surg Oncol. 2004 Feb;11(2):178-86 [14761921.001]
  • [Cites] Ann Intern Med. 2004 Apr 20;140(8):W33 [15096365.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G7-17 [15194558.001]
  • [Cites] Acta Chir Scand. 1973;139(4):392-400 [4718184.001]
  • [Cites] J Histochem Cytochem. 1987 Sep;35(9):983-96 [3302022.001]
  • [Cites] Cancer. 1990 Oct 1;66(7):1636-40 [2208015.001]
  • [Cites] Ann Surg. 1994 Feb;219(2):112-9 [8129481.001]
  • (PMID = 18299935.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA082312-08; United States / NCI NIH HHS / CA / R01 CA082312; United States / NCI NIH HHS / CA / CA82312; United States / NCI NIH HHS / CA / R01 CA082312-08
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / DNA Probes; 0 / MUC2 protein, human; 0 / MUC5AC protein, human; 0 / Mucin 5AC; 0 / Mucin-2; 0 / Mucins; 0 / RNA Probes
  • [Other-IDs] NLM/ NIHMS72052; NLM/ PMC2570966
  •  go-up   go-down


6. Yang W, Velcich A, Lozonschi I, Liang J, Nicholas C, Zhuang M, Bancroft L, Augenlicht LH: Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- mice. Am J Pathol; 2005 Apr;166(4):1239-46
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Muc2(-/-) mice develop tumors in the small and large intestine and the rectum, but in contrast to tumors in Apc1638(+/-) mice, this does not involve increased expression or nuclear localization of beta-catenin.

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oncogene. 1996 Feb 15;12(4):893-901 [8632912.001]
  • [Cites] Cell Growth Differ. 1995 Jun;6(6):749-57 [7669730.001]
  • [Cites] Annu Rev Physiol. 1996;58:253-73 [8815795.001]
  • [Cites] Am J Pathol. 1996 Aug;149(2):381-7 [8701978.001]
  • [Cites] Mol Cell Biol. 1996 Aug;16(8):4088-94 [8754807.001]
  • [Cites] J Biol Chem. 1997 Mar 21;272(12):7968-76 [9065467.001]
  • [Cites] Science. 1997 Mar 21;275(5307):1784-7 [9065401.001]
  • [Cites] Science. 1997 Mar 21;275(5307):1787-90 [9065402.001]
  • [Cites] Curr Top Microbiol Immunol. 1997;224:137-46 [9308237.001]
  • [Cites] Oncogene. 1998 Apr 23;16(16):2141-50 [9572495.001]
  • [Cites] Surgery. 1998 Aug;124(2):248-53 [9706145.001]
  • [Cites] Science. 1998 Sep 4;281(5382):1509-12 [9727977.001]
  • [Cites] Am J Physiol. 1999 Jan;276(1 Pt 1):G115-24 [9886986.001]
  • [Cites] Exp Cell Res. 1999 Feb 1;246(2):280-9 [9925742.001]
  • [Cites] Oncogene. 1999 Jan 28;18(4):979-85 [10023673.001]
  • [Cites] Mol Cell Biol. 1999 Aug;19(8):5696-706 [10409758.001]
  • [Cites] Gastroenterology. 2005 Apr;128(4):1081-8 [15825089.001]
  • [Cites] EMBO J. 1999 Nov 1;18(21):5931-42 [10545105.001]
  • [Cites] Bioessays. 1999 Dec;21(12):1021-30 [10580987.001]
  • [Cites] Cancer Res. 1999 Dec 1;59(23):6005-9 [10606249.001]
  • [Cites] J Cell Biol. 2001 Jan 8;152(1):87-96 [11149923.001]
  • [Cites] Cancer Res. 2001 Jan 15;61(2):565-9 [11212250.001]
  • [Cites] Cancer Res. 2001 Jan 15;61(2):570-6 [11212251.001]
  • [Cites] Cancer Res. 2001 Apr 15;61(8):3465-71 [11309309.001]
  • [Cites] Oncogene. 2001 Jun 7;20(26):3387-98 [11423989.001]
  • [Cites] Cancer Res. 2001 Aug 15;61(16):6297-302 [11507085.001]
  • [Cites] Science. 2002 Mar 1;295(5560):1726-9 [11872843.001]
  • [Cites] Science. 2002 Jul 5;297(5578):102-4 [12098700.001]
  • [Cites] Nature. 2002 Oct 17;419(6908):729-34 [12384701.001]
  • [Cites] J Biol Chem. 2002 Nov 1;277(44):41417-22 [12202477.001]
  • [Cites] Cell. 2002 Oct 18;111(2):241-50 [12408868.001]
  • [Cites] J Nutr. 2002 Dec;132(12):3804S-3808S [12468628.001]
  • [Cites] Oncogene. 2003 Jan 23;22(3):351-60 [12545156.001]
  • [Cites] Exp Cell Res. 2003 Feb 1;283(1):17-21 [12565816.001]
  • [Cites] J Biol Chem. 2003 Aug 8;278(32):30348-55 [12759355.001]
  • [Cites] Cancer Res. 2003 Aug 15;63(16):4990-6 [12941825.001]
  • [Cites] Cancer Res. 1995 Jul 1;55(13):2910-9 [7796420.001]
  • [Cites] Gastroenterology. 1995 Aug;109(2):516-23 [7615201.001]
  • [Cites] Gastroenterology. 1995 Sep;109(3):999-1001 [7657131.001]
  • [Cites] Cell. 1995 Aug 25;82(4):675-84 [7664346.001]
  • [Cites] Cancer Res. 1996 May 15;56(10):2250-5 [8625293.001]
  • (PMID = 15793302.001).
  • [ISSN] 0002-9440
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA096605; United States / NCI NIH HHS / CA / CA100926; United States / NCI NIH HHS / CA / CA96605; United States / PHS HHS / / P01 13330; United States / NCI NIH HHS / CA / R01 CA087559; United States / NCI NIH HHS / CA / CA87559; United States / NCI NIH HHS / CA / U54 CA100926
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cdkn1a protein, mouse; 0 / Cdkn1b protein, mouse; 0 / Cell Cycle Proteins; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Muc2 protein, mouse; 0 / Mucin-2; 0 / Mucins; 0 / Myc protein, mouse; 0 / Proto-Oncogene Proteins c-myc; 0 / Tumor Suppressor Proteins; 147604-94-2 / Cyclin-Dependent Kinase Inhibitor p27
  • [Other-IDs] NLM/ PMC1602374
  •  go-up   go-down


7. Zuo L, Zhang SM, Hu RL, Zhu HQ, Zhou Q, Gui SY, Wu Q, Wang Y: Correlation between expression and differentiation of endocan in colorectal cancer. World J Gastroenterol; 2008 Jul 28;14(28):4562-8
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Expression of endocan in 72 tumor tissue samples of colorectal cancer as well as in 27 normal mucous membrane tissue samples was analyzed using in situ hybridization, immunohistochemistry on tissue microarray, Western blot and reverse-transcript polymerase chain reaction (RT-PCR).
  • RESULTS: The expression of endocan was higher in normal colon and rectum tissue samples than in cancerous tissue samples (mRNA = 92.6%, protein = 36%), and was lower in colorectal cancer tissue samples (mRNA = 70.4%, protein = 36.1%).
  • [MeSH-major] Adenocarcinoma / metabolism. Colorectal Neoplasms / metabolism. Neoplasm Proteins / metabolism. Proteoglycans / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Case-Control Studies. Cell Transformation, Neoplastic / metabolism. Cell Transformation, Neoplastic / pathology. Colon / metabolism. Colon / pathology. Down-Regulation. Female. Humans. Intestinal Mucosa / metabolism. Intestinal Mucosa / pathology. Male. Middle Aged. RNA, Messenger / metabolism. Rectum / metabolism. Rectum / pathology. Young Adult

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Blood. 2000 Nov 1;96(9):3139-46 [11049995.001]
  • [Cites] Dis Aquat Organ. 2007 May 9;75(3):183-90 [17629112.001]
  • [Cites] Eur J Biochem. 2001 Aug;268(16):4423-9 [11502202.001]
  • [Cites] Eur J Cancer. 2001 Oct;37 Suppl 8:S4-66 [11602373.001]
  • [Cites] Br J Cancer. 2001 Nov 30;85(11):1713-21 [11742493.001]
  • [Cites] J Biol Chem. 2001 Dec 21;276(51):48341-9 [11590178.001]
  • [Cites] Nature. 2002 Jan 31;415(6871):530-6 [11823860.001]
  • [Cites] Microvasc Res. 2002 Mar;63(2):159-71 [11866539.001]
  • [Cites] Semin Cancer Biol. 2002 Jun;12(3):173-86 [12083848.001]
  • [Cites] Oncogene. 2002 Jul 18;21(31):4765-77 [12101415.001]
  • [Cites] Cancer Res. 2004 Feb 1;64(3):844-56 [14871811.001]
  • [Cites] Lancet Oncol. 2004 May;5(5):292-302 [15120666.001]
  • [Cites] BMC Cancer. 2003 Nov 27;3:31 [14641932.001]
  • [Cites] Am J Respir Crit Care Med. 2004 Jul 15;170(2):167-74 [15087295.001]
  • [Cites] Cancer. 1974 May;33(5):1480-4 [4823490.001]
  • [Cites] J Biol Chem. 1996 Aug 23;271(34):20458-64 [8702785.001]
  • [Cites] Cancer. 1997 Nov 1;80(9):1803-4 [9351551.001]
  • [Cites] J Histochem Cytochem. 1998 Mar;46(3):397-403 [9487122.001]
  • [Cites] J Biol Chem. 1998 Oct 23;273(43):28116-21 [9774430.001]
  • [Cites] Matrix Biol. 2004 Oct;23(6):341-52 [15533755.001]
  • [Cites] Nature. 2004 Nov 18;432(7015):332-7 [15549095.001]
  • [Cites] Oncogene. 2005 Feb 3;24(6):1104-10 [15690056.001]
  • [Cites] CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 [15761078.001]
  • [Cites] Biochim Biophys Acta. 2006 Jan;1765(1):25-37 [16168566.001]
  • [Cites] Crit Care Med. 2006 Feb;34(2):532-7 [16424738.001]
  • [Cites] Proteomics. 2006 Feb;6(3):767-74 [16400680.001]
  • [Cites] Microvasc Res. 2006 Nov;72(3):136-45 [16956626.001]
  • [Cites] J Clin Invest. 2001 Aug;108(3):349-55 [11489925.001]
  • (PMID = 18680240.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / ESM1 protein, human; 0 / Neoplasm Proteins; 0 / Proteoglycans; 0 / RNA, Messenger
  • [Other-IDs] NLM/ PMC2731287
  •  go-up   go-down


8. Pedersen ME, Rahr HB, Fenger C, Qvist N: Adenocarcinoma arising from the rectal stump eleven years after excision of an ileal J-pouch in a patient with ulcerative colitis: report of a case. Dis Colon Rectum; 2008 Jul;51(7):1146-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma arising from the rectal stump eleven years after excision of an ileal J-pouch in a patient with ulcerative colitis: report of a case.
  • All previously reported cases have occurred in patients with their ileal pouch in situ.
  • We report a case of adenocarcinoma in the anal canal 11 years after removal of a failed ileal J-pouch.
  • [MeSH-major] Adenocarcinoma, Mucinous / etiology. Colitis, Ulcerative / surgery. Colonic Pouches / pathology. Rectal Neoplasms / etiology
  • [MeSH-minor] Anastomosis, Surgical. Biopsy. Diagnosis, Differential. Fatal Outcome. Follow-Up Studies. Humans. Ileostomy. Male. Middle Aged. Proctocolectomy, Restorative / methods. Time Factors. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Ulcerative Colitis.
  • MedlinePlus Health Information. consumer health - Ulcerative Colitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18437493.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


9. Morello E, Martano M, Squassino C, Iussich S, Caccamo R, Sammartano F, Zabarino S, Bellino C, Pisani G, Buracco P: Transanal pull-through rectal amputation for treatment of colorectal carcinoma in 11 dogs. Vet Surg; 2008 Jul;37(5):420-6
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transanal pull-through rectal amputation for treatment of colorectal carcinoma in 11 dogs.
  • OBJECTIVE: To evaluate outcome after transanal rectal pull-through amputation of single colorectal adenocarcinoma and in situ carcinoma (Tis) in dogs.
  • RESULTS: Adenocarcinoma (8) and Tis (2) were removed with 3-6 cm of grossly normal tissue, cranial and caudal to the tumor, or in 1 Tis with 2 cm grossly normal tissue, cranial and caudal.
  • In the other dogs, postoperative complications included short-term tenesmus (6 dogs), rectal bleeding (11), rectal stricture (3), and long-term fecal incontinence (1).
  • Postoperative recurrence and metastatic rates for adenocarcinoma were 18.2% and 0%, respectively.
  • CONCLUSION: En bloc excision of colorectal Tis and adenocarcinoma may be followed by a long survival.
  • CLINICAL RELEVANCE: Transanal rectal pull-through amputation is suitable for en bloc resection of colorectal neoplasia.
  • A combined abdominal-transanal approach should be reserved for tumors extending from the mid-cranial region of the rectum to the descending colon.
  • [MeSH-major] Adenocarcinoma / veterinary. Anal Canal / surgery. Colorectal Neoplasms / veterinary. Dog Diseases / surgery
  • [MeSH-minor] Animals. Disease-Free Survival. Dogs. Fecal Incontinence / epidemiology. Fecal Incontinence / veterinary. Female. Male. Neoplasm Recurrence, Local / veterinary. Postoperative Complications / epidemiology. Postoperative Complications / veterinary. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18986308.001).
  • [ISSN] 1532-950X
  • [Journal-full-title] Veterinary surgery : VS
  • [ISO-abbreviation] Vet Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Zeng GX, Wang YL, Dai LH, Xiong JR, Qi PL: [New concept and clinical application of colorectal intraepithelial neoplasia and carcinoma]. Zhonghua Wai Ke Za Zhi; 2007 Apr 1;45(7):449-51
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [New concept and clinical application of colorectal intraepithelial neoplasia and carcinoma].
  • OBJECTIVE: To introduce the WHO 2000 diagnostic criteria of biopsy of colorectal intraepithelial neoplasia and carcinoma and to enhance diagnostic accuracy and avoid overdiagnosis and underdiagnosis.
  • METHOD: The postoperative pathological examination and preoperative biopsy in 56 patients diagnosed as colorectal intraepithelial neoplasia and carcinoma before operation from January 2001 to October 2005 were compared retrospectively.
  • RESULTS: Among the 56 cases, 16 patients were diagnosed by preoperative biopsy as carcinoma in situ, intramucosal carcinoma and adenocarcinoma, but according to the new standard, of them 14 cases should be revised to be higher grade colorectal intraepithelial neoplasia.
  • CONCLUSIONS: Strictly adhere to the new WHO criteria, colorectal intraepithelial neoplasia and carcinoma can be diagnosed properly, but for the cases that submucosal muscular layer would not presented in biopsy, the diagnosis should be made by combining clinical findings and various examination results so as to avoid underdiagnosis and delay of treatment.
  • [MeSH-major] Carcinoma / diagnosis. Carcinoma in Situ / diagnosis. Colorectal Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Biopsy. Colon / pathology. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Preoperative Care. Rectum / pathology. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17686298.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


11. Caputi Iambrenghi O, Ugenti I, Martines G, Marino F, Francesco Altomare D, Memeo V: Endoscopic management of large colorectal polyps. Int J Colorectal Dis; 2009 Jul;24(7):749-53
MedlinePlus Health Information. consumer health - Endoscopy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Fifteen polyps were located in the rectum, 84 in the sigmoid colon, 11 in the descending colon, four in the splenic flexure, 11 in the transverse colon, 11 in the hepatic flexure, seven in the ascending colon and eight in the cecum.
  • At histology, most of polyps (131) were adenomas (nine with adenocarcinoma in situ).
  • [MeSH-major] Colonic Polyps / surgery. Endoscopy. Rectum / pathology. Rectum / surgery

  • MedlinePlus Health Information. consumer health - Colonic Polyps.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19259689.001).
  • [ISSN] 1432-1262
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


12. Szanto I, Rubbia-Brandt L, Kiss P, Steger K, Banfi B, Kovari E, Herrmann F, Hadengue A, Krause KH: Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol; 2005 Oct;207(2):164-76
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • NOX1 mRNA expression was assessed by dot-blot hybridization, real-time PCR and in situ hybridization, using samples derived from surgical specimens from patients undergoing colon resection.
  • [MeSH-minor] Adenocarcinoma / metabolism. Adult. Aged. Aged, 80 and over. Animals. Colitis, Ulcerative / metabolism. Colon / metabolism. Crohn Disease / metabolism. Female. Humans. Ileum / metabolism. In Situ Hybridization / methods. Lymphocytes / metabolism. Male. Mice. Mice, Inbred BALB C. Middle Aged. Neoplasm Proteins / analysis. RNA, Messenger / analysis. RNA, Neoplasm / analysis. Rectal Neoplasms / metabolism. Rectum / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
  • (PMID = 16086438.001).
  • [ISSN] 0022-3417
  • [Journal-full-title] The Journal of pathology
  • [ISO-abbreviation] J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / Reactive Oxygen Species; EC 1.6.3.- / NOX1 protein, human; EC 1.6.3.1 / NADPH Oxidase
  •  go-up   go-down


13. Eriksen MT, Wibe A, Norstein J, Haffner J, Wiig JN, Norwegian Rectal Cancer Group: Anastomotic leakage following routine mesorectal excision for rectal cancer in a national cohort of patients. Colorectal Dis; 2005 Jan;7(1):51-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anastomotic leakage following routine mesorectal excision for rectal cancer in a national cohort of patients.
  • OBJECTIVE: Mesorectal excision is successfully implemented as the standard surgical technique for rectal cancer resections in Norway.
  • METHODS: This was a prospective national cohort study of 1958 patients undergoing rectal cancer surgery with anterior resection in Norway from November 1993 to December 1999.
  • [MeSH-major] Adenocarcinoma / surgery. Anastomosis, Surgical / adverse effects. Carcinoma in Situ / surgery. Colon / surgery. Rectal Neoplasms / surgery. Rectum / surgery

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15606585.001).
  • [ISSN] 1462-8910
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


14. Brouwer R, MacDonald A, Matthews R, Gunn J, Monson JR, Hartley JE: Brush cytology for the diagnosis of colorectal cancer. Dis Colon Rectum; 2009 Apr;52(4):598-601
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Brush cytology for the diagnosis of colorectal cancer.
  • PURPOSE: The purpose of this study was to analyze the results of brush cytology for the diagnosis of colorectal cancer and compare them with the results of endoscopic biopsy and histologic evaluation of the resected specimen.
  • RESULTS: Cytology alone had a sensitivity of 88.2 percent, a specificity of 94.1 percent, a positive predictive value of 98.6 percent, and a negative predictive value of 61.9 percent for the diagnosis of colorectal cancer.
  • Combining the results of brush cytology and biopsy resulted in a statistically significant increase in sensitivity to 97.4 percent (P < 0.001), a significant increase in the negative predictive value to 88.4 percent (P < 0.001), and a significant reduction in the false-negative rate to 0.03 percent (P < 0.001) for the diagnosis of colorectal cancer.
  • CONCLUSIONS: Brush cytology is as accurate as endoscopic biopsy for the diagnosis of colorectal cancer, and combining these two diagnostic modalities resulted in a significant improvement in the definitive diagnosis of cancer, which might reduce the need for further biopsy.
  • [MeSH-major] Colorectal Neoplasms / diagnosis
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Carcinoma in Situ / diagnosis. Carcinoma in Situ / pathology. Humans. Retrospective Studies. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19404060.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Manxhuka-Kerliu S, Telaku S, Ahmetaj H, Baruti A, Loxha S, Kerliu A: Colorectal cancer: prognostic values. Bosn J Basic Med Sci; 2009 Feb;9(1):19-24
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenocarcinoma was the most frequent histological type found in 85,90% of cases, in 60,94% of males and 39,06% of females; squamous cell carcinoma in 7,38%, in 63,63% of males and 36,36% of females; mucinous carcinoma in 4,68%, in 57,15% of males and 42,85% of females; while adenosquamous carcinoma, undifferentiated carcinoma and carcinoma in situ in 0,71% of cases each.

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19284390.001).
  • [ISSN] 1512-8601
  • [Journal-full-title] Bosnian journal of basic medical sciences
  • [ISO-abbreviation] Bosn J Basic Med Sci
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Bosnia and Herzegovina
  •  go-up   go-down


16. Xiao XY, Zhou XY, Yan G, Sun MH, Du X: Chromosomal alteration in Chinese sporadic colorectal carcinomas detected by comparative genomic hybridization. Diagn Mol Pathol; 2007 Jun;16(2):96-103
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The gains of 4q, 7q, 20q and losses of 9p, 18q were related with the sites (P<0.05), colon and rectum, respectively; gain of 20q and loss of 9p were commonly found in the colon cancer; gain of 4q, 7q and loss of 18q were easily seen in the rectal cancer.
  • The development mechanisms of colon cancer and rectal cancer may not be completely similar.
  • [MeSH-major] Adenocarcinoma / genetics. Chromosome Aberrations. Colorectal Neoplasms / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Asian Continental Ancestry Group. China / ethnology. Chromosome Banding. DNA, Neoplasm / analysis. Female. Humans. In Situ Hybridization. Male. Middle Aged. RNA, Neoplasm / analysis. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17525679.001).
  • [ISSN] 1052-9551
  • [Journal-full-title] Diagnostic molecular pathology : the American journal of surgical pathology, part B
  • [ISO-abbreviation] Diagn. Mol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / RNA, Neoplasm
  •  go-up   go-down


17. DeSimone CP, Day ME, Tovar MM, Dietrich CS 3rd, Eastham ML, Modesitt SC: Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature. Obstet Gynecol; 2006 Jun;107(6):1285-91
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Seventeen women (21%) had preinvasive disease: cervical intraepithelial neoplasia 2 or 3, adenocarcinoma in situ and endometrial hyperplasia, whereas 14 women (17%) had invasive adenocarcinomas of the endometrium, cervix, ovary, and rectum.
  • Specifically, they were more likely to have preinvasive disease and less likely to have invasive carcinoma.
  • CONCLUSION: Atypical glandular cell cytology confers a risk (38%) of either preinvasive disease or carcinoma, with the risk of carcinoma increasing significantly for women aged older than 40.
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adolescent. Adult. Aged. Aged, 80 and over. Colposcopy. Electrosurgery / statistics & numerical data. Female. Genital Neoplasms, Female / epidemiology. Health Planning Guidelines. Humans. Middle Aged. Practice Guidelines as Topic

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Obstet Gynecol. 2006 Oct;108(4):1034 [17012481.001]
  • (PMID = 16738153.001).
  • [ISSN] 0029-7844
  • [Journal-full-title] Obstetrics and gynecology
  • [ISO-abbreviation] Obstet Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Bucher P, Pugin F, Morel P: Single-port access laparoscopic radical left colectomy in humans. Dis Colon Rectum; 2009 Oct;52(10):1797-801
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Umbilical single-port access (embryonic natural orifice transluminal endoscopic surgery) left colectomy was performed in a patient with sigmoid colon adenocarcinoma in situ.
  • Final diagnosis revealed an adenocarcinoma in situ.

  • MedlinePlus Health Information. consumer health - Colonic Polyps.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Dis Colon Rectum. 2009 Oct;52(10):1801-2 [19966618.001]
  • (PMID = 19966617.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Joseph DA, Miller JW, Wu X, Chen VW, Morris CR, Goodman MT, Villalon-Gomez JM, Williams MA, Cress RD: Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer; 2008 Nov 15;113(10 Suppl):2892-900
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The following anal cancer histologies were included in the analysis: squamous cell, adenocarcinoma, and small cell/neuroendocrine carcinomas.
  • Squamous cell carcinoma (SCC) was the most common histology overall, accounting for 18,105 of 21,395 (84.6%) cases of anal cancer.
  • The majority of SCC cases were diagnosed at the in situ or localized stage (58.1%).

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Natl Cancer Inst. 2000 Sep 20;92(18):1500-10 [10995805.001]
  • [Cites] Cancer. 2000 Mar 15;88(6):1464-9 [10717631.001]
  • [Cites] Clin Infect Dis. 2002 Nov 1;35(9):1127-34 [12384848.001]
  • [Cites] AIDS. 2003 Feb 14;17(3):311-20 [12556684.001]
  • [Cites] Prev Med. 2003 May;36(5):555-60 [12689800.001]
  • [Cites] Dis Colon Rectum. 2003 Nov;46(11):1517-23; discussion 1523-4; author reply 1524 [14605572.001]
  • [Cites] Cancer Causes Control. 2003 Nov;14(9):837-46 [14682441.001]
  • [Cites] Lancet Oncol. 2004 Mar;5(3):149-57 [15003197.001]
  • [Cites] Cancer. 2004 Jul 15;101(2):270-80 [15241823.001]
  • [Cites] Cancer. 2004 Jul 15;101(2):281-8 [15241824.001]
  • [Cites] N Engl J Med. 1987 Oct 15;317(16):973-7 [2821396.001]
  • [Cites] Gastroenterology. 1988 Jul;95(1):107-11 [2836255.001]
  • [Cites] Am J Epidemiol. 1992 Jan 15;135(2):180-9 [1311142.001]
  • [Cites] Am J Epidemiol. 1992 Jul 1;136(1):54-8 [1329500.001]
  • [Cites] Am J Epidemiol. 1994 Apr 15;139(8):772-80 [8178790.001]
  • [Cites] Am J Epidemiol. 1994 Jul 1;140(1):12-9 [8017399.001]
  • [Cites] N Engl J Med. 1997 Nov 6;337(19):1350-8 [9358129.001]
  • [Cites] Semin Cancer Biol. 1998 Aug;8(4):307-13 [9870037.001]
  • [Cites] Cancer Res. 1999 Feb 1;59(3):753-7 [9973228.001]
  • [Cites] JAMA. 1999 May 19;281(19):1822-9 [10340370.001]
  • [Cites] Clin Infect Dis. 2006 Jul 15;43(2):223-33 [16779751.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2006 Oct 27;55(42):1145-8 [17065979.001]
  • [Cites] Stat Methods Med Res. 2006 Dec;15(6):547-69 [17260923.001]
  • [Cites] Lancet Oncol. 2007 Apr;8(4):311-6 [17395104.001]
  • [Cites] Am J Surg Pathol. 2007 Jun;31(6):919-25 [17527081.001]
  • [Cites] Clin Microbiol Rev. 2007 Jul;20(3):478-88, table of contents [17630336.001]
  • [Cites] Sex Transm Infect. 2007 Jul;83(4):257-66 [17664359.001]
  • [Cites] Cancer Causes Control. 2007 Dec;18(10):1175-86 [17805982.001]
  • [Cites] Cancer. 2008 Nov 15;113(10 Suppl):2841-54 [18980203.001]
  • [Cites] Dermatol Ther. 2005 Jan-Feb;18(1):67-76 [15842614.001]
  • [Cites] Dan Med Bull. 2002 Aug;49(3):194-209 [12238281.001]
  • (PMID = 18980293.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] ENG
  • [Grant] None / None / / N01 PC035137; United States / NCCDPHP CDC HHS / DP / U50 DP424071; United States / NCI NIH HHS / PC / N01 PC035137; United States / NCCDPHP CDC HHS / DP / U50 DP424071-04
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS104103; NLM/ PMC2729501
  •  go-up   go-down


20. Vainer G, Vainer-Mosse E, Pikarsky A, Shenoy SM, Oberman F, Yeffet A, Singer RH, Pikarsky E, Yisraeli JK: A role for VICKZ proteins in the progression of colorectal carcinomas: regulating lamellipodia formation. J Pathol; 2008 Aug;215(4):445-56
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A role for VICKZ proteins in the progression of colorectal carcinomas: regulating lamellipodia formation.
  • VICKZ proteins are a highly conserved family of RNA binding proteins, implicated in RNA regulatory processes such as intracellular RNA localization, RNA stability, and translational control.
  • During embryogenesis, VICKZ proteins are required for neural crest migration and in adults, the proteins are overexpressed primarily in different cancers.
  • We hypothesized that VICKZ proteins may play a role in cancer cell migration.
  • In patients, VICKZ expression varies with tumour type, with over 60% of colon, lung, and ovarian tumours showing strong expression.
  • In colorectal carcinomas (CRCs), expression is detected at early stages, and the frequency and intensity of staining increase with progression of the disease to lymph node metastases, of which 97% express the protein at high levels.
  • Indeed, in stage II CRC, the level of VICKZ expression in the primary lesion correlates with the degree of lymph node metastasis.
  • In culture, VICKZ proteins rapidly accumulate in processes at the leading edge of PMA-stimulated SW480 CRC cells, where they co-localize with beta-actin mRNA.
  • Two distinct cocktails of shRNAs, each targeting all three VICKZ paralogues, cause a dramatic drop in lamellipodia and ruffle formation in stimulated cells.
  • Thus, VICKZ proteins help to facilitate the dynamic cell surface morphology required for cell motility.
  • We propose that these proteins play an important role in CRC metastasis by shuttling requisite RNAs to the lamellipodia of migrating cells.

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
  • [Cites] J Cell Sci. 1995 Aug;108 ( Pt 8):2781-90 [7593319.001]
  • [Cites] J Cell Biol. 1994 Sep;126(5):1221-9 [8063859.001]
  • [Cites] J Cell Biol. 1997 Mar 24;136(6):1263-70 [9087442.001]
  • [Cites] Oncogene. 1997 Jun 5;14(22):2729-33 [9178771.001]
  • [Cites] Biol Cell. 1997 May;89(2):113-22 [9351191.001]
  • [Cites] Genes Dev. 1998 Jun 1;12(11):1593-8 [9620847.001]
  • [Cites] Cancer Res. 1999 Mar 15;59(6):1202-5 [10096548.001]
  • [Cites] J Exp Med. 1999 Apr 5;189(7):1101-10 [10190901.001]
  • [Cites] J Biol Chem. 2004 Nov 19;279(47):48716-24 [15355996.001]
  • [Cites] Cancer Res. 2004 Dec 1;64(23):8585-94 [15574765.001]
  • [Cites] Biol Cell. 2005 Jan;97(1):87-96 [15601260.001]
  • [Cites] Biol Cell. 2005 Jan;97(1):97-110 [15601261.001]
  • [Cites] Am J Surg Pathol. 2005 Feb;29(2):188-95 [15644775.001]
  • [Cites] Science. 2005 Mar 25;307(5717):1976-8 [15731405.001]
  • [Cites] Oncologist. 2005 May;10(5):332-4 [15851791.001]
  • [Cites] J Biol Chem. 2005 May 6;280(18):18517-24 [15753088.001]
  • [Cites] J Cell Sci. 2005 Jun 1;118(Pt 11):2425-33 [15923655.001]
  • [Cites] J Clin Oncol. 2005 Jul 10;23(20):4545-52 [16002846.001]
  • [Cites] Reproduction. 2005 Aug;130(2):203-12 [16049158.001]
  • [Cites] Nature. 2005 Nov 24;438(7067):512-5 [16306994.001]
  • [Cites] EMBO J. 2006 Apr 5;25(7):1456-68 [16541107.001]
  • [Cites] Mol Biol Cell. 2006 Jun;17(6):2581-91 [16597702.001]
  • [Cites] Nature. 2006 Jun 15;441(7095):898-901 [16778892.001]
  • [Cites] Lancet Oncol. 2006 Jul;7(7):556-64 [16814207.001]
  • [Cites] Nat Neurosci. 2006 Oct;9(10):1247-56 [16980963.001]
  • [Cites] J Cell Biol. 2006 Nov 20;175(4):527-34 [17101699.001]
  • [Cites] Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):434-42 [17255263.001]
  • [Cites] Haematologica. 2007 Feb;92(2):176-83 [17296566.001]
  • [Cites] Biochim Biophys Acta. 2007 May;1773(5):642-52 [16926057.001]
  • [Cites] Mol Cell Proteomics. 2007 May;6(5):798-811 [17289661.001]
  • [Cites] RNA. 2007 Sep;13(9):1558-69 [17652133.001]
  • [Cites] Int J Cancer. 2003 Mar 10;104(1):54-9 [12532419.001]
  • [Cites] Oncogene. 2000 Mar 16;19(12):1519-28 [10734311.001]
  • [Cites] Nature. 2000 Aug 3;406(6795):532-5 [10952316.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7045-50 [11416185.001]
  • [Cites] Oncogene. 2001 Oct 4;20(45):6544-50 [11641779.001]
  • [Cites] Gene. 2002 Apr 3;287(1-2):49-54 [11992722.001]
  • [Cites] J Cell Biol. 2003 Jan 6;160(1):77-87 [12507992.001]
  • [Cites] Cancer Res. 2003 Jan 1;63(1):119-24 [12517787.001]
  • [Cites] Curr Biol. 2003 Feb 4;13(3):199-207 [12573215.001]
  • [Cites] Cell. 2003 Feb 21;112(4):453-65 [12600310.001]
  • [Cites] Br J Cancer. 2003 Mar 24;88(6):887-94 [12644826.001]
  • [Cites] Development. 2003 Dec;130(23):5649-61 [14522877.001]
  • [Cites] Cancer Res. 2004 Jan 1;64(1):209-14 [14729626.001]
  • [Cites] Science. 2004 Apr 30;304(5671):743-6 [15118165.001]
  • [Cites] Int J Biochem Cell Biol. 2004 Oct;36(10):1890-909 [15203104.001]
  • [Cites] Cell. 1986 May 9;45(3):407-15 [3698103.001]
  • [Cites] Dis Colon Rectum. 1991 Jun;34(6):458-63 [2036925.001]
  • [Cites] J Cell Biol. 1994 Sep;126(5):1211-9 [8063858.001]
  • [Cites] Mol Cell Biol. 1997 Apr;17(4):2158-65 [9121465.001]
  • (PMID = 18535985.001).
  • [ISSN] 0022-3417
  • [Journal-full-title] The Journal of pathology
  • [ISO-abbreviation] J. Pathol.
  • [Language] ENG
  • [Grant] United States / NIAMS NIH HHS / AR / R01 AR041480-13; United States / NIGMS NIH HHS / GM / R01 GM084364-17; United States / NIAMS NIH HHS / AR / R01 AR041480-11; United States / NIAMS NIH HHS / AR / AR041480-06; United States / NIAMS NIH HHS / AR / AR041480-11; United States / NIGMS NIH HHS / GM / R01 GM084364-15A1; United States / NIAMS NIH HHS / AR / R01 AR041480-10A2; United States / NIAMS NIH HHS / AR / AR041480-10A2; United States / NIAMS NIH HHS / AR / AR041480-09; United States / NIAMS NIH HHS / AR / R01 AR041480; United States / NIGMS NIH HHS / GM / R01 GM084364-18; United States / NIAMS NIH HHS / AR / R01 AR041480-09; United States / NIAMS NIH HHS / AR / AR041480-08; United States / NIAMS NIH HHS / AR / R01 AR041480-06; United States / NIAMS NIH HHS / AR / R01 AR041480-14; United States / NIGMS NIH HHS / GM / R01 GM084364-16; United States / NIAMS NIH HHS / AR / R01 AR041480-08; United States / NIAMS NIH HHS / AR / R01 AR041480-11S1; United States / NIAMS NIH HHS / AR / R01 AR041480-12; United States / NIGMS NIH HHS / GM / R01 GM084364
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 0 / ZBP1 protein, human
  • [Other-IDs] NLM/ NIHMS314194; NLM/ PMC3148580
  •  go-up   go-down


21. Castillo PA, Aguilar VC, Wexner S, Davila GW: Uterine retroversion for vaginoperineal reconstruction following resection of distal rectal tumors. Dis Colon Rectum; 2010 Mar;53(3):350-4
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine retroversion for vaginoperineal reconstruction following resection of distal rectal tumors.
  • PURPOSE: Vaginal and perineal reconstruction following wide resection of locally invasive rectal cancer can be challenging.
  • We present a technique applicable to nonhysterectomized patients who undergo posterior vaginal wall reconstruction with retroversion of the in situ uterus.
  • METHODS: Four nonhysterectomized patients with recurrent rectal carcinoma and abdominoperineal resection with en bloc resection of the posterior vagina leaving a large defect necessitating reconstruction of the vagina, perineum, or both, have undergone posterior vaginal wall and perineal reconstruction with uterine retroversion into the posterior pelvis and fixation to the perineum.
  • [MeSH-major] Adenocarcinoma / surgery. Carcinoma, Squamous Cell / surgery. Perineum / surgery. Reconstructive Surgical Procedures / methods. Rectal Neoplasms / surgery. Uterus / surgery. Vagina / surgery
  • [MeSH-minor] Adult. Female. Humans. Middle Aged. Neoplasm Recurrence, Local. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20173485.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Bodaghi S, Yamanegi K, Xiao SY, Da Costa M, Palefsky JM, Zheng ZM: Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res; 2005 Apr 15;11(8):2862-7
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The samples were processed in a blinded fashion for nested PCR and in situ PCR detection of HPV DNAs.
  • In situ PCR detection of the tumor tissues confirmed the presence of HPV DNA in tumor cells.

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Natl Cancer Inst Monogr. 2003;(31):52-6 [12807946.001]
  • [Cites] Cancer Res. 2003 Nov 1;63(21):7515-9 [14612553.001]
  • [Cites] Arch Surg. 1990 Jul;125(7):862-5 [2164371.001]
  • [Cites] Science. 1991 Jun 21;252(5013):1643-51 [2047872.001]
  • [Cites] Am J Surg Pathol. 1992 Mar;16(3):269-75 [1317997.001]
  • [Cites] Gastroenterology. 2001 Mar;120(4):988-94 [11231953.001]
  • [Cites] J Natl Cancer Inst. 2000 May 3;92(9):709-20 [10793107.001]
  • [Cites] Cancer Res. 1999 Dec 15;59(24):6132-6 [10626803.001]
  • [Cites] J Clin Microbiol. 2000 Jan;38(1):357-61 [10618116.001]
  • [Cites] Eur J Cancer Prev. 1998 Aug;7(4):305-13 [9806119.001]
  • [Cites] N Engl J Med. 1997 Nov 6;337(19):1350-8 [9358129.001]
  • [Cites] J Gen Virol. 1995 Apr;76 ( Pt 4):1057-62 [9049358.001]
  • [Cites] Gut. 1995 Jul;37(1):87-90 [7672688.001]
  • [Cites] J Clin Microbiol. 1995 Apr;33(4):901-5 [7790457.001]
  • [Cites] J Surg Oncol. 1992 Sep;51(1):5-7 [1325576.001]
  • [Cites] Am J Surg. 1993 Dec;166(6):738-40; discussion 741-2 [8273860.001]
  • [Cites] Int J Cancer. 2003 Apr 10;104(3):336-44 [12569557.001]
  • [Cites] CA Cancer J Clin. 2003 Jan-Feb;53(1):5-26 [12568441.001]
  • [Cites] Clin Cancer Res. 2002 Oct;8(10):3187-92 [12374687.001]
  • [Cites] J Clin Pathol. 2002 Oct;55(10):721-8 [12354793.001]
  • [Cites] Int J Colorectal Dis. 2002 Nov;17(6):396-401 [12355215.001]
  • [Cites] J Med Virol. 2002 Nov;68(3):412-6 [12226830.001]
  • [Cites] Nat Rev Cancer. 2002 May;2(5):342-50 [12044010.001]
  • [Cites] J Infect Dis. 2002 May 1;185(9):1229-37 [12001039.001]
  • [Cites] J Clin Virol. 2001 May;21(2):129-34 [11378493.001]
  • [Cites] J Microbiol Immunol Infect. 2001 Jun;34(2):87-91 [11456365.001]
  • [Cites] Pathologica. 2001 Oct;93(5):531-4 [11725354.001]
  • [Cites] Cancer Res. 2001 Apr 1;61(7):2799-803 [11306446.001]
  • (PMID = 15837733.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA8340201; United States / NCI NIH HHS / SC / Z01 SC010357-06
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral
  • [Other-IDs] NLM/ NIHMS8365; NLM/ PMC1479314
  •  go-up   go-down


23. Horst D, Kriegl L, Engel J, Kirchner T, Jung A: CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer; 2008 Oct 21;99(8):1285-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In addition, CD133+ cells are characterised in situ by lack of CK20 expression, whereas they are positive for EpCAM.
  • Our results indicate that in colorectal cancer, the CD133+ tumour cells can be detected by immunohistochemistry, which facilitates their further characterisation in situ.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenocarcinoma / mortality. Antigens, CD / biosynthesis. Colorectal Neoplasms / metabolism. Colorectal Neoplasms / mortality. Glycoproteins / biosynthesis

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cell Stem Cell. 2007 Oct 11;1(4):389-402 [18371377.001]
  • [Cites] Cell Stem Cell. 2007 Sep 13;1(3):313-23 [18371365.001]
  • [Cites] J Biol Chem. 2000 Feb 25;275(8):5512-20 [10681530.001]
  • [Cites] Nature. 2001 Nov 1;414(6859):105-11 [11689955.001]
  • [Cites] Histopathology. 2002 Feb;40(2):127-32 [11952856.001]
  • [Cites] Dis Colon Rectum. 1993 Jul;36(7):627-35 [8348847.001]
  • [Cites] Blood. 1997 Dec 15;90(12):5013-21 [9389721.001]
  • [Cites] Nat Rev Cancer. 2005 Sep;5(9):744-9 [16148886.001]
  • [Cites] J Pathol. 2006 Jul;209(3):287-97 [16770755.001]
  • [Cites] Nature. 2007 Jan 4;445(7123):111-5 [17122771.001]
  • [Cites] Nature. 2007 Jan 4;445(7123):106-10 [17122772.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63 [17548814.001]
  • [Cites] J Pathol. 2008 Jan;214(1):3-9 [18067118.001]
  • [Cites] Gut. 2008 Apr;57(4):538-48 [18334662.001]
  • [Cites] Br J Cancer. 2008 Apr 22;98(8):1389-97 [18349830.001]
  • (PMID = 18781171.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / AC133 antigen; 0 / Antigens, CD; 0 / Biomarkers, Tumor; 0 / Glycoproteins; 0 / Peptides
  • [Other-IDs] NLM/ PMC2570510
  •  go-up   go-down


24. Atkin GK, Daley FM, Bourne S, Glynne-Jones R, Northover JM, Wilson GD: The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery. Br J Cancer; 2006 Oct 9;95(7):928-33
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery.
  • Tumour expression of thymidylate synthase, thymidine phosphorylase, cyclin A, vascular endothelial growth factor (VEGF), carbonic anhydrase-9, hypoxia inducible factor-1alpha, and glucose transporter-1 (GLUT-1) proteins was determined before and after rectal cancer surgery.
  • Colorectal cancer surgery significantly impacts on intratumoral gene expression, suggesting archival specimens may not accurately reflect in situ marker levels.
  • Although rectal cancer was the studied model, the results may be applicable to any solid tumour undergoing extirpation in which molecular markers have been proposed to guide patient therapy.
  • [MeSH-major] Adenocarcinoma / surgery. Biomarkers, Tumor / metabolism. Gene Expression. Ischemia / metabolism. Rectal Neoplasms / surgery
  • [MeSH-minor] Aged. Aged, 80 and over. Digestive System Surgical Procedures / adverse effects. Female. Humans. Immunohistochemistry. Male. Middle Aged. Prognosis. Rectum / blood supply. Thymidylate Synthase / metabolism

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 2006 Jan 16;94(1):121-7 [16404365.001]
  • [Cites] Hum Pathol. 2005 Dec;36(12):1302-8 [16311124.001]
  • [Cites] Am J Med Sci. 1993 Jul;306(1):37-41 [8328508.001]
  • [Cites] Pharm World Sci. 1994 Apr 15;16(2):84-103 [7518280.001]
  • [Cites] Nucleic Acids Res. 1995 Nov 25;23(22):4649-56 [8524656.001]
  • [Cites] Clin Cancer Res. 2000 Mar;6(3):1063-72 [10741735.001]
  • [Cites] Clin Cancer Res. 2000 Apr;6(4):1378-84 [10778966.001]
  • [Cites] Eur J Cancer. 2000 Aug;36(13 Spec No):1649-60 [10959051.001]
  • [Cites] Nature. 2000 Aug 17;406(6797):747-52 [10963602.001]
  • [Cites] Cancer Res. 2000 Dec 15;60(24):7075-83 [11156414.001]
  • [Cites] Oncol Rep. 2001 May-Jun;8(3):497-500 [11295069.001]
  • [Cites] J Surg Res. 2001 Aug;99(2):222-7 [11469890.001]
  • [Cites] J Natl Cancer Inst. 2001 Sep 5;93(17):1337-43 [11535709.001]
  • [Cites] Cancer Treat Rev. 2002 Feb;28(1):27-47 [12027413.001]
  • [Cites] Mol Cell Biol. 2003 Jan;23(1):359-69 [12482987.001]
  • [Cites] J Clin Oncol. 2003 Jan 15;21(2):241-50 [12525515.001]
  • [Cites] Oncol Rep. 2003 Jul-Aug;10(4):867-9 [12792736.001]
  • [Cites] Anal Biochem. 2004 May 15;328(2):101-8 [15113684.001]
  • [Cites] Breast Cancer Res. 2004;6(4):R450-9 [15217513.001]
  • [Cites] Exp Mol Pathol. 2004 Dec;77(3):222-30 [15507240.001]
  • [Cites] Biochemistry. 1974 Jan 29;13(3):471-81 [4203910.001]
  • [Cites] J Biol Chem. 1987 Mar 25;262(9):4098-103 [3549724.001]
  • [Cites] Cancer Res. 1997 Feb 15;57(4):570-2 [9044826.001]
  • [Cites] Exp Physiol. 1997 Mar;82(2):361-8 [9129950.001]
  • [Cites] Clin Cancer Res. 1998 Oct;4(10):2371-6 [9796967.001]
  • [Cites] Histopathology. 1989 Dec;15(6):653-8 [2606461.001]
  • (PMID = 17016487.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 2.1.1.45 / Thymidylate Synthase
  • [Other-IDs] NLM/ PMC2360543
  •  go-up   go-down


25. Haveri H, Westerholm-Ormio M, Lindfors K, Mäki M, Savilahti E, Andersson LC, Heikinheimo M: Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa. BMC Gastroenterol; 2008;8:9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Samples of normal and neoplastic gastrointestinal tract from children and adults were subjected to RNA in situ hybridization with 33P labelled probes and immunohistochemistry, using an avidin-biotin immunoperoxidase system.
  • The pathological tissues examined included samples of chronic and atrophic gastritis as well as adenomas and adenocarcinomas of the colon and rectum.
  • GATA-6 expression was reduced in colon carcinoma.
  • [MeSH-major] Adenocarcinoma / genetics. Adenoma / genetics. Colonic Neoplasms / genetics. GATA4 Transcription Factor / metabolism. GATA6 Transcription Factor / metabolism. Gastric Mucosa / metabolism. Rectal Neoplasms / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Cell Endocrinol. 2005 Apr 15;233(1-2):47-56 [15767045.001]
  • [Cites] Genes Dev. 1997 Apr 15;11(8):1061-72 [9136933.001]
  • [Cites] Gastroenterology. 2005 Nov;129(5):1696-710 [16285967.001]
  • [Cites] Cancer Biol Ther. 2005 Oct;4(10):1050-4 [16258256.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Aug;291(2):G297-306 [16603485.001]
  • [Cites] Gastroenterology. 2006 Jul;131(1):14-29 [16831586.001]
  • [Cites] Mol Cell Biol. 2006 Dec;26(23):9060-70 [16940177.001]
  • [Cites] Dev Biol. 2002 Jan 1;241(1):34-46 [11784093.001]
  • [Cites] Cancer Res. 2002 Feb 15;62(4):1178-83 [11861401.001]
  • [Cites] Mol Cell. 2002 Feb;9(2):279-89 [11864602.001]
  • [Cites] Genes Dev. 2002 Apr 1;16(7):784-9 [11937486.001]
  • [Cites] Biochim Biophys Acta. 2002 Jun 7;1576(1-2):198-202 [12031502.001]
  • [Cites] Endocrinology. 2002 Aug;143(8):3136-43 [12130579.001]
  • [Cites] Biochim Biophys Acta. 2000 Feb 29;1490(3):324-32 [10684977.001]
  • [Cites] Mol Carcinog. 2000 Jul;28(3):184-8 [10942535.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Sep;85(9):3476-83 [10999851.001]
  • [Cites] Circ Res. 2000 Oct 13;87(8):699-704 [11029406.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2001 Jan;280(1):G58-67 [11123198.001]
  • [Cites] Front Biosci. 2001 Oct 1;6:D1321-57 [11578958.001]
  • [Cites] FEBS Lett. 1997 May 19;408(2):121-3 [9187350.001]
  • [Cites] Am J Physiol. 1998 Feb;274(2 Pt 1):G314-24 [9486185.001]
  • [Cites] Mol Cell Biol. 1998 May;18(5):2901-11 [9566909.001]
  • [Cites] Development. 1998 Dec;125(24):4909-17 [9811575.001]
  • [Cites] Genes Dev. 1998 Nov 15;12(22):3579-90 [9832509.001]
  • [Cites] Front Biosci. 1999 Mar 15;4:D286-98 [10077541.001]
  • [Cites] J Cancer Res Clin Oncol. 1999;125(2):71-6 [10190312.001]
  • [Cites] Circ Res. 1999 Apr 2;84(6):647-54 [10189352.001]
  • [Cites] Mol Med. 1999 Jul;5(7):490-501 [10449810.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Dec 17;325(3):952-60 [15541382.001]
  • [Cites] Clin Cancer Res. 2004 Dec 1;10(23):7917-24 [15585625.001]
  • [Cites] J Cell Physiol. 2005 Apr;203(1):15-26 [15389642.001]
  • [Cites] J Mol Histol. 2005 Feb;36(1-2):15-24 [15703995.001]
  • [Cites] Hum Pathol. 2002 Jun;33(6):660-8 [12152167.001]
  • [Cites] J Pathol. 2002 Aug;197(5):582-8 [12210076.001]
  • [Cites] Mol Pharmacol. 2003 Feb;63(2):368-77 [12527808.001]
  • [Cites] J Biol Chem. 2003 Feb 14;278(7):4705-12 [12468531.001]
  • [Cites] Cancer Res. 2003 Aug 15;63(16):4967-77 [12941822.001]
  • [Cites] Mol Cell Biol. 2003 Dec;23(23):8429-39 [14612389.001]
  • [Cites] Nat Genet. 2004 Mar;36(3):277-82 [14770182.001]
  • [Cites] Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):77-99 [15000151.001]
  • [Cites] Int J Cancer. 2004 Jul 10;110(5):668-76 [15146555.001]
  • [Cites] Pathol Int. 2004 Jun;54(6):408-12 [15144399.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2004 Oct;287(4):G899-909 [15178553.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2004 Nov;287(5):G1086-99 [14715527.001]
  • [Cites] Blood. 1992 Aug 1;80(3):575-81 [1638017.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10876-80 [8248184.001]
  • [Cites] Dev Biol. 1994 Aug;164(2):361-73 [8045339.001]
  • [Cites] Dev Biol. 1996 Jul 10;177(1):309-22 [8660897.001]
  • [Cites] Gastroenterology. 1997 May;112(5):1559-67 [9136834.001]
  • [Cites] Genes Dev. 1997 Apr 15;11(8):1048-60 [9136932.001]
  • [Cites] Gut. 2005 Sep;54(9):1321-31 [16099799.001]
  • (PMID = 18405344.001).
  • [ISSN] 1471-230X
  • [Journal-full-title] BMC gastroenterology
  • [ISO-abbreviation] BMC Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / GATA4 Transcription Factor; 0 / GATA6 Transcription Factor; 0 / RNA, Messenger
  • [Other-IDs] NLM/ PMC2323380
  •  go-up   go-down


26. Cimitan A, Burza A, Basile U, Saputo S, Mingazzini P, Stipa F: [Local excision of giant rectal polypoid neoplasms]. Chir Ital; 2008 May-Jun;60(3):345-53

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Local excision of giant rectal polypoid neoplasms].
  • Local excision is the best therapeutic option for giant adenomas of the rectum.
  • Parks technique for lower rectal lesions and the T.E.M. technique for lesions localised in the middle and upper rectum offer exceptionally good exposure, allowing radical excision in the case of early low-risk T1 adenocarcinomas (well or moderately differentiated [G1/2] without lymphovascular invasion [L0]).
  • From July 1987 to March 2006, 224 patients were treated by local excision for rectal lesions in our department.
  • In 3 patients with a preoperative diagnosis of severe dysplasia (Tis) final pathology showed adenoma and for this reason they were included in our study group.
  • Twenty-five (49%) patients had a definitive diagnosis of adenocarcinoma: in situ (pTis) in 22 patients (88%), pT1 in 2 patients (8%) and pT2 in 1 patient (4%).
  • In 26 patients (51%) the diagnosis was adenoma.
  • Giant sessile polypoid lesions localized in the middle and upper rectum are best treated with T.E.M., while Parks technique is a good option in lower rectal tumours.
  • [MeSH-major] Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18709772.001).
  • [ISSN] 0009-4773
  • [Journal-full-title] Chirurgia italiana
  • [ISO-abbreviation] Chir Ital
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down






Advertisement